Hong-Wei Su
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- RNA and protein synthesis mechanisms
Papers in
-
- Circular RNAs in diseases 3
- RNA modifications and cancer 3
- Renal and related cancers 2
-
- Renal Diseases and Glomerulopathies 3
- Chronic Kidney Disease and Diabetes 3
- Co-authors
- Xu Zhang (1 shared paper)Song Wu (1 shared paper)Chong Li (1 shared paper)Tao Tao (1 shared paper)Xing Kang (1 shared paper)Zhao Yang (1 shared paper)Ruizhi Tan (10 shared papers)Li Wang (7 shared papers)
- Journals
- Renal Failure (2 papers)International Immunopharmacology (2 papers)Phytomedicine (2 papers)International Journal of Biological Sciences (1 paper)Physiological Genomics (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hong-Wei Su
16 papers receiving 254 citations
Peers
Comparison fields: 5 of 54
- Cancer Research 136
- Molecular Biology 194
- Nephrology 14
- Molecular Medicine 6
- Pulmonary and Respiratory Medicine 28
Countries citing papers authored by Hong-Wei Su
This map shows the geographic impact of Hong-Wei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong-Wei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong-Wei Su more than expected).
Fields of papers citing papers by Hong-Wei Su
This network shows the impact of papers produced by Hong-Wei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong-Wei Su. The network helps show where Hong-Wei Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Hong-Wei Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 133 | |
| 2 | 2011 | 31 | |
| 3 | 2018 | 24 | |
| 4 | 2023 | 16 | |
| 5 | 2024 | 7 | |
| 6 | 2018 | 7 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 5 | |
| 9 | 2020 | 5 | |
| 10 | 2024 | 5 | |
| 11 | 2024 | 4 | |
| 12 | 2025 | 3 | |
| 13 | 2025 | 3 | |
| 14 | 2024 | 3 | |
| 15 | 2014 | 3 | |
| 16 | 2025 | 2 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2024 | 0 | |
| 20 | 2025 | 0 |
About Hong-Wei Su
Hong-Wei Su is a scholar working on Molecular Biology, Nephrology, Immunology, Infectious Diseases and Cardiology and Cardiovascular Medicine, having authored 20 papers that have together received 257 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (3 papers), Circular RNAs in diseases (3 papers), Renal Diseases and Glomerulopathies (3 papers), RNA modifications and cancer (3 papers), Chronic Kidney Disease and Diabetes (3 papers), Renal and related cancers (2 papers), Renin-Angiotensin System Studies (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (136 citations), Molecular Biology (194 citations), Nephrology (14 citations), Molecular Medicine (6 citations) and Pulmonary and Respiratory Medicine (28 citations). Hong-Wei Su has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xu Zhang, Song Wu, Chong Li, Tao Tao, Xing Kang, Zhao Yang, Ruizhi Tan, Li Wang, Wenzhong Liu and Lingyang Xu. Their work appears in journals such as Renal Failure, International Immunopharmacology, Phytomedicine, International Journal of Biological Sciences and Physiological Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.